TG THERAPEUTICS, INC. — Revenue by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/36886799-896b-4dd6-be11-000a072f7d32/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $616.3M | 2025-01-01 – 2025-12-31 | evidence 0001437749-26-006133 |
| FY 2024 | $329.0M | 2024-01-01 – 2024-12-31 | evidence 0001437749-25-005908 |
| FY 2023 | $233.7M | 2023-01-01 – 2023-12-31 | evidence 0001437749-24-006144 |
| FY 2022 | $2.8M | 2022-01-01 – 2022-12-31 | evidence 0001437749-24-006144 |
| FY 2021 | $6.7M | 2021-01-01 – 2021-12-31 | evidence 0001437749-24-006144 |
| FY 2020 | $152.0k | 2020-01-01 – 2020-12-31 | evidence 0001558370-21-002149 |
| FY 2019 | $152.0k | 2019-01-01 – 2019-12-31 | evidence 0001558370-20-001897 |
| FY 2018 | $152.0k | 2018-01-01 – 2018-12-31 | evidence 0001654954-19-002189 |
| FY 2017 | $152.0k | 2017-01-01 – 2017-12-31 | evidence 0001654954-19-002189 |
| FY 2016 | $152.0k | 2016-01-01 – 2016-12-31 | evidence 0001654954-19-002189 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
TG THERAPEUTICS, INC. — all facts · Net Income · Operating Income